FT商学院

Why is AI struggling to discover new drugs?
为什么AI很难发现新药?

A generation of start-ups have failed to live up to the hype. Executives are now betting that more powerful tools will crack the complexities of human biology
上一代初创企业未能兑现当时的夸张宣传。企业高管如今押注更强大的AI工具将攻克人体生物学的复杂难点。

In the mid-2010s, a spate of start-ups hoping to transform the laborious process of finding new drugs launched with big promises. Artificial intelligence would dramatically reduce the time it took to discover new medicines and cut the average of $2bn it takes to develop a drug. 

2010年代中期,一批初创企业带着宏大愿景涌现,试图改造耗时费力的新药发掘流程。人工智能(AI)将显著缩短发现新药所需的时间,并降低开发一款药物所需的平均成本(约20亿美元)。

您已阅读2%(367字),剩余98%(19458字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×